Caffeine and Sodium Benzoate (Page 2 of 2)

Serialization Label

Serialization Label
(click image for full-size original)
CAFFEINE AND SODIUM BENZOATE
caffeine and sodium benzoate injection, solution
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:0517-2502
Route of Administration INTRAMUSCULAR, INTRAVENOUS DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
CAFFEINE (CAFFEINE) CAFFEINE 125 mg in 1 mL
Inactive Ingredients
Ingredient Name Strength
SODIUM BENZOATE 125 mg in 1 mL
HYDROCHLORIC ACID
SODIUM HYDROXIDE
WATER
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:0517-2502-10 10 VIAL, SINGLE-DOSE in 1 BOX contains a VIAL, SINGLE-DOSE (0517-2502-01)
1 NDC:0517-2502-01 2 mL in 1 VIAL, SINGLE-DOSE This package is contained within the BOX (0517-2502-10)
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
unapproved drug other 02/01/1993
Labeler — American Regent, Inc. (002033710)
Establishment
Name Address ID/FEI Operations
American Regent, Inc. 002033710 analysis (0517-2502), manufacture (0517-2502)

Revised: 12/2019 American Regent, Inc.

Page 2 of 2 1 2

All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.

This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.

Privacy Policy | Copyright © 2024. All Rights Reserved.